Covering the struggles, celebrations, and everyday realities of LGBTQ+ people — here, there, and everywhere.

Protests at Alice Schwarzer’s Book Reading in Hamburg

Protests at Alice Schwarzer’s Book Reading in Hamburg

March 20, 2026

A reading by activist and publicist Alice Schwarzer at the Deutsches Schauspielhaus in Hamburg was interrupted by protests. On several

March 19, 2026

Tails and Sheep: Peter Hujar’s Photographic Diversity

So much Peter Hujar has never been shown before—from Bonn to Berlin. The Bundeskunsthalle and

March 19, 2026

Barbra Streisand to Receive Cannes’ Honorary Palme

Barbra Streisand, the American icon who is now 83, is set to receive the Palme

March 19, 2026

Moderna Cancels Vaccine Development, Possibly for STIs

On February 11, Moderna, the U.S. pharmaceutical company, was informed in a “Refusal-to-File” letter from

March 18, 2026

Is the Mustache in Style Right Now?

At the Oscars, Leonardo DiCaprio’s mustache was one of the night’s eye-catching details. Beards, whether

March 18, 2026

A Queer Couple Fights the LGBTQ Rights Rollback in the U.S.

With his novel “Transinternetwork Foundation – The Story of Aaron and Tamara,” Tom Real crafts

March 18, 2026

Heated Rivalry: Fans Can Rent the Cottage for Themselves

Fans of the queer hit series “Heated Rivalry” now have a once-in-a-lifetime chance to step

March 18, 2026

Nitrous Oxide Ban Takes Effect on April 12

The nationwide ban on nitrous oxide, which has increasingly circulated as a party drug among

NEW JOURNALS ON TRAVEL

March 20, 2026

Protests at Alice Schwarzer’s Book Reading in Hamburg

A reading by activist and publicist Alice Schwarzer at the Deutsches Schauspielhaus in Hamburg was

March 19, 2026

Tails and Sheep: Peter Hujar’s Photographic Diversity

So much Peter Hujar has never been shown before—from Bonn to Berlin. The Bundeskunsthalle and

March 19, 2026

Barbra Streisand to Receive Cannes’ Honorary Palme

Barbra Streisand, the American icon who is now 83, is set to receive the Palme

March 19, 2026

Moderna Cancels Vaccine Development, Possibly for STIs

On February 11, Moderna, the U.S. pharmaceutical company, was informed in a “Refusal-to-File” letter from